Novel Bioventures - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $57,815.27 +2.69%
Ethereum $3,067.47 +2.33%
BNB $516.37 +1.93%
Optimism $1.57 +8.21%
Arbitrum $0.70 +5.78%
Solana $142.15 +2.78%
Polygon $0.50 +0.56%
Cosmos $5.90 +0.83%
Avalanche $26.16 +3.36%

Bitcoin $57,815.27 +2.69%
Ethereum $3,067.47 +2.33%
BNB $516.37 +1.93%
Optimism $1.57 +8.21%
Arbitrum $0.70 +5.78%
Solana $142.15 +2.78%
Polygon $0.50 +0.56%
Cosmos $5.90 +0.83%
Avalanche $26.16 +3.36%

Novel Bioventures

investment firm

Summary
Investments
Exits

About

Novel Bioventures is a venture capital fund focused on early stage investments.

Gaithersburg,Maryland,United States
http://www.noblebioventures.com

Highlights

Lead Investments

Details

Operating Status: Active
Investor Type: Venture Capital

Investments

Number of Investments

Number of Lead Investments

4

1

Novel Bioventures has made 4 investments. Their most recent investment was on May 11, 2005, when Cellerant Therapeutics raised $16M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
May 11, 2005 Cellerant Therapeutics	Series B	$16M	Biotechnology	Yes
Jan 27, 2005 Predix Pharmaceuticals	Series C	$43M	Health Care	—
Jun 1, 2004 ARYx Therapeutics	Series D	$55M	Biotechnology	—
Jan 27, 2004 TransMedics	Series B	$27.60M	Health Care	—

Exits

Novel Bioventures has had 3 exits. Novel Bioventures most notable exits include TransMedics , ARYx Therapeutics

Date	Company Name	Exit Type	Industry
May 1, 2019	TransMedics	IPO	Health Care	Detail
Nov 7, 2007	ARYx Therapeutics	IPO	Biotechnology	Detail
Oct 26, 2005	Predix Pharmaceuticals	M&A	Health Care	Detail